|
US7141244B1
(en)
*
|
1992-03-02 |
2006-11-28 |
Chiron Srl |
Helicobacter pylori proteins useful for vaccines and diagnostics
|
|
JPH10502365A
(ja)
*
|
1994-07-01 |
1998-03-03 |
リカン・リミテッド |
ヘリコバクタータンパク質およびワクチン
|
|
WO1997025429A1
(en)
*
|
1996-01-04 |
1997-07-17 |
Rican Limited |
Helicobacter pylori bacterioferritin
|
|
EP2298900A1
(en)
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
|
AU1979599A
(en)
*
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
|
EP2261352A3
(en)
|
1998-05-01 |
2012-01-04 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
|
US6610306B2
(en)
*
|
1998-10-22 |
2003-08-26 |
The University Of Montana |
OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
|
|
ATE527360T1
(de)
|
1998-12-08 |
2011-10-15 |
Glaxosmithkline Biolog Sa |
Neue verbindungen abgeleitet von neisseria meningitidis
|
|
CA2360667A1
(en)
|
1999-01-22 |
2000-07-27 |
Smithkline Beecham Biologicals S.A. |
Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof
|
|
CA2365102A1
(en)
|
1999-03-12 |
2000-09-21 |
Smithkline Beecham Biologicals S.A. |
Neisseria meningitidis antigenic polypeptides and encoding polynucleotides and uses thereof
|
|
CN101033467A
(zh)
*
|
1999-04-30 |
2007-09-12 |
希龙公司 |
奈瑟球菌基因组序列及其用法
|
|
JP2003518363A
(ja)
|
1999-04-30 |
2003-06-10 |
カイロン エセ．ピー．アー． |
保存されたナイセリア抗原
|
|
EP2270173B1
(en)
|
1999-05-19 |
2016-01-06 |
GlaxoSmithKline Biologicals SA |
Combination neisserial compositions
|
|
AU2013203304B2
(en)
*
|
1999-05-19 |
2014-10-09 |
Glaxosmithkline Biologicals S.A. |
Combination Neisserial compositions
|
|
AU2003271337B2
(en)
*
|
1999-08-03 |
2005-07-21 |
Smithkline Beecham Biologicals S.A. |
Vaccine composition
|
|
RU2281956C2
(ru)
|
1999-10-29 |
2006-08-20 |
Чирон С.Р.Л. |
Антигенные пептиды neisseria
|
|
CA2390344C
(en)
*
|
1999-11-29 |
2014-08-26 |
Chiron Spa |
85kda neisserial antigen
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
PT2289545T
(pt)
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
|
ES2281409T3
(es)
|
2000-02-28 |
2007-10-01 |
Novartis Vaccines And Diagnostics S.R.L. |
Expresion heterologa de proteinas de neisseria.
|
|
GB0011108D0
(en)
*
|
2000-05-08 |
2000-06-28 |
Microscience Ltd |
Virulence gene and protein and their use
|
|
GB0012079D0
(en)
*
|
2000-05-18 |
2000-07-12 |
Microscience Ltd |
Virulence gene and protein, and their use
|
|
US6936261B2
(en)
|
2000-07-27 |
2005-08-30 |
Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
|
|
GB0020952D0
(en)
*
|
2000-08-24 |
2000-10-11 |
Microscience Ltd |
Genes and proteins and their uses
|
|
EP1315815B1
(en)
*
|
2000-09-09 |
2007-04-18 |
Degussa GmbH |
Nucleotide sequences which code for the dep34 gene
|
|
DK1328543T3
(da)
|
2000-10-27 |
2009-11-23 |
Novartis Vaccines & Diagnostic |
Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
|
|
GB0107219D0
(en)
*
|
2001-03-22 |
2001-05-16 |
Microbiological Res Authority |
Immunogenic commensal neisseria sequences
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
GB0108024D0
(en)
*
|
2001-03-30 |
2001-05-23 |
Chiron Spa |
Bacterial toxins
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
BR0211494A
(pt)
|
2001-07-27 |
2004-08-17 |
Chiron Srl |
Adesinas de meningococo nada, app e orf 40
|
|
JP2005506322A
(ja)
*
|
2001-08-31 |
2005-03-03 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
|
|
CN100354297C
(zh)
*
|
2001-10-03 |
2007-12-12 |
希龙公司 |
辅助的脑膜炎球菌组合物
|
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
CN100515494C
(zh)
|
2001-12-12 |
2009-07-22 |
启龙有限公司 |
抗沙眼衣原体的免疫
|
|
EP2572707A3
(en)
|
2002-02-20 |
2013-11-06 |
Novartis Vaccines and Diagnostics, Inc. |
Microparticles with adsorbed polypeptide-containing molecules
|
|
EP1495039A4
(en)
*
|
2002-03-20 |
2006-07-26 |
Univ Emory |
MUTANTS OF NEISSERIA, LIPOOLIGOSACCHARIDES AND IMMUNOGENIC COMPOSITIONS
|
|
EP1524991A1
(en)
*
|
2002-08-02 |
2005-04-27 |
GlaxoSmithKline Biologicals S.A. |
Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
GB0220205D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Neisseria toxin
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
HUE031886T2
(en)
|
2002-10-11 |
2017-08-28 |
Glaxosmithkline Biologicals Sa |
Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
|
|
EP2395073B1
(en)
|
2002-11-01 |
2017-09-06 |
GlaxoSmithKline Biologicals S.A. |
Drying process
|
|
US7807802B2
(en)
|
2002-11-12 |
2010-10-05 |
Abbott Lab |
Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
AU2003299994A1
(en)
|
2002-12-27 |
2004-07-29 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
EP1631264B8
(en)
|
2003-06-02 |
2017-05-24 |
GlaxoSmithKline Biologicals SA |
Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
CN103357002A
(zh)
|
2003-10-02 |
2013-10-23 |
诺华疫苗和诊断有限公司 |
多种脑膜炎球菌血清群的液体疫苗
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
JP2008504292A
(ja)
|
2004-06-24 |
2008-02-14 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
免疫増強用の化合物
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
EP1784211A4
(en)
|
2004-07-29 |
2010-06-30 |
Novartis Vaccines & Diagnostic |
IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE
|
|
ES2616294T3
(es)
|
2005-01-27 |
2017-06-12 |
Children's Hospital & Research Center At Oakland |
Vacunas de vesículas basadas en GNA1870 para protección de amplio espectro contra enfermedades provocadas por Neisseria meningitidis
|
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
|
GB0502096D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
|
CA2626253A1
(en)
|
2005-10-18 |
2007-04-26 |
Novartis Vaccines And Diagnostics, Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
|
CA2630220C
(en)
|
2005-11-22 |
2020-10-13 |
Doris Coit |
Norovirus and sapovirus antigens
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
CA2646539A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
|
CA2656474A1
(en)
|
2006-06-29 |
2008-01-03 |
Novartis Ag |
Polypeptides from neisseria meningitidis
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
CA2699513C
(en)
|
2007-09-12 |
2018-03-13 |
Novartis Ag |
Gas57 mutant antigens and gas57 antibodies
|
|
WO2009050586A1
(en)
|
2007-10-19 |
2009-04-23 |
Novartis Ag |
Meningococcal vaccine formulations
|
|
EP3067048B1
(en)
|
2007-12-07 |
2018-02-14 |
GlaxoSmithKline Biologicals SA |
Compositions for inducing immune responses
|
|
PL2235046T3
(pl)
|
2007-12-21 |
2012-12-31 |
Novartis Ag |
Zmutowane formy streptolizyny O
|
|
CN102356089B
(zh)
|
2008-02-21 |
2014-02-19 |
诺华股份有限公司 |
脑膜炎球菌fHBP多肽
|
|
PT2268618E
(pt)
|
2008-03-03 |
2015-10-12 |
Novartis Ag |
Compostos e composições moduladores da actividade tlr
|
|
SI2349520T1
(sl)
|
2008-10-27 |
2016-08-31 |
Glaxosmithkline Biologicals S.A. |
Postopek čiščenja za ogljikohidrat iz Streptococcus skupine A
|
|
US9175353B2
(en)
|
2008-11-14 |
2015-11-03 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
|
AU2010203223B9
(en)
|
2009-01-05 |
2015-10-08 |
Epitogenesis Inc. |
Adjuvant compositions and methods of use
|
|
CN102481349B
(zh)
|
2009-01-12 |
2014-10-15 |
诺华股份有限公司 |
抗革兰氏阳性细菌疫苗中的Cna_B结构域
|
|
HUE049695T2
(hu)
|
2009-03-24 |
2020-10-28 |
Glaxosmithkline Biologicals Sa |
Adjuváló H meningococcus faktort kötõ fehérje
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
CA2765112A1
(en)
|
2009-06-10 |
2010-12-16 |
Novartis Ag |
Benzonaphthyridine-containing vaccines
|
|
ES2443952T3
(es)
|
2009-09-02 |
2014-02-21 |
Novartis Ag |
Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
|
|
JO3257B1
(ar)
|
2009-09-02 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات كمعدلات لفاعلية tlr
|
|
US8974799B2
(en)
|
2009-09-30 |
2015-03-10 |
Novartis Ag |
Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
|
|
BR112012010223A2
(pt)
|
2009-10-30 |
2016-12-06 |
Novartis Ag |
purificação de staphylococcus aureus tipo 5 e tipo 8 sacarídeos capsulares
|
|
WO2011057148A1
(en)
|
2009-11-05 |
2011-05-12 |
Irm Llc |
Compounds and compositions as tlr-7 activity modulators
|
|
SG10201501980SA
(en)
|
2009-12-15 |
2015-05-28 |
Novartis Ag |
Homogeneous suspension of immunopotentiating compounds and uses thereof
|
|
AU2011232421B2
(en)
|
2010-03-23 |
2015-08-13 |
Novartis Ag |
Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
|
|
KR20130121699A
(ko)
|
2010-05-28 |
2013-11-06 |
테트리스 온라인, 인코포레이티드 |
상호작용 혼성 비동기 컴퓨터 게임 기반구조
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
KR101594228B1
(ko)
|
2010-08-23 |
2016-02-15 |
와이어쓰 엘엘씨 |
네이세리아 메닌기티디스 ｒＬＰ２０８６ 항원의 안정한 제제
|
|
GB201014967D0
(en)
*
|
2010-09-09 |
2010-10-20 |
Univ Southampton |
Composition
|
|
NZ607224A
(en)
|
2010-09-10 |
2014-11-28 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
|
BR112013005626B1
(pt)
|
2010-09-10 |
2022-07-26 |
Glaxosmithkline Biologicals Sa |
Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
WO2012085668A2
(en)
|
2010-12-24 |
2012-06-28 |
Novartis Ag |
Compounds
|
|
CN107837394A
(zh)
|
2011-06-24 |
2018-03-27 |
埃皮托吉尼西斯有限公司 |
作为抗原特异性免疫调节剂的包含选择的载体、维生素、单宁和类黄酮的组合的药物组合物
|
|
MX359256B
(es)
|
2012-03-09 |
2018-09-19 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MX357538B
(es)
|
2012-06-14 |
2018-07-13 |
Novartis Ag |
Vacunas para meningococo de serogrupo x.
|
|
AU2013295242C1
(en)
|
2012-07-27 |
2018-08-09 |
Institut National De La Sante Et De La Recherche Medicale |
CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
|
|
AR092897A1
(es)
|
2012-10-03 |
2015-05-06 |
Novartis Ag |
Composiciones inmunogenicas
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
AU2016221318B2
(en)
|
2015-02-19 |
2020-06-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US11612664B2
(en)
|
2016-04-05 |
2023-03-28 |
Gsk Vaccines S.R.L. |
Immunogenic compositions
|
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
BR112020001255A2
(pt)
|
2017-07-21 |
2020-07-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
composições imunogênicas de neisseria meningitidis
|
|
WO2019075053A1
(en)
*
|
2017-10-11 |
2019-04-18 |
Elanco Us Inc. |
PORCINE G-CSF VARIANTS AND USES THEREOF
|
|
CN109161546B
(zh)
*
|
2018-09-20 |
2021-11-09 |
广西科学院 |
一种核酸适配体及其在检测卵形鲳鲹源致病性溶藻弧菌中的应用
|
|
EP4034157A1
(en)
|
2019-09-27 |
2022-08-03 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2025006737A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine
|